secwatch.observer — SEC 8-K summary
======================================

Issuer:     TANDEM DIABETES CARE INC (TNDM)
CIK:        0001438133
Form:       8-K
Filed at:   2026-05-15T11:59:42+00:00
Accession:  0001438133-26-000052
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Tandem Diabetes terminates CCO Mark Novara without cause; last day May 18
-------------------------------------------------------------------------

- Mark Novara, EVP & Chief Commercial Officer, notified of termination without cause on May 11, 2026.
- His last day of employment is scheduled to be May 18, 2026.
- Company states its strategy and 2026 goals remain unchanged.
- No successor has been announced as of the filing date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1438133/000143813326000052/0001438133-26-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1438133/000143813326000052/tndm-20260511.htm
  HTML page:      https://secwatch.observer/filing/0001438133-26-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer